PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 9, 20260 citationsOpen Access

Use of chloroquine, hydroxychloroquine or ivermectin for Covid-19 prevention in vulnerable Brazilian populations.

View Full Paper
DCDébora CastanheiraTTThiago Silva TorresTAThais Regis Aranha

Key Points

  • This research aims to explore factors associated with the use of chloroquine, hydroxychloroquine, and ivermectin for Covid-19 prevention in vulnerable populations in Brazil.
  • Cross-sectional study conducted from July 2022 to July 2023.
  • Data collected from 19 primary healthcare units in Salvador and Rio de Janeiro.
  • Logistic regression analyzed factors related to drug use and assessed multicollinearity.
  • 11.7% of participants reported using chloroquine, hydroxychloroquine, or ivermectin for prevention.
  • Increased use was seen in Brown individuals (ORa = 1.38; 95%CI 1.10-1.75) and those aged 35-59.
  • Unvaccinated individuals living with someone with comorbidities had significantly higher odds of drug use (ORa = 10.34; 95%CI 2.27-53.48).

Abstract

OBJECTIVE: To explore factors associated with the use of chloroquine, hydroxychloroquine, and ivermectin for Covid-19 prevention in socioeconomically vulnerable populations in Brazil. METHODS: A cross-sectional study was conducted using data from the project "Expansion of testing, quarantine, digital health, and telemonitoring strategies to tackle the Covid-19 pandemic in Brazil. " Participants were users of 19 primary healthcare units in Salvador (Bahia, BA) and Rio de Janeiro (Rio de Janeiro, RJ) from July 2022 to July 2023. Data were collected via a socioeconomic questionnaire and analyzed using logistic regression to assess factors associated with the use of chloroquine, hydroxychloroquine, or ivermectin for Covid-19 prevention. Multicollinearity was assessed using the generalized variance inflation factor (GVIF), with GVIF^ (1/ (2*df) ) > 5 indicating potential collinearity. Sensitivity analyses were performed using the same backward selection procedure as the main model: excluding "sometimes" responses and stratifying analyses by city (Rio de Janeiro and Salvador). RESULTS: Among 7, 505 participants, 11. 7% reported using chloroquine, hydroxychloroquine, or ivermectin for Covid-19 prevention. Use was more frequent among people who identified themselves as Brown (ORa = 1. 38; 95%CI 1. 10-1. 75), aged 35-44 (ORa = 1. 34; 95%CI 1. 03-1. 75) or 44-59 (ORa = 1. 36; 95%CI 1. 06-1. 77), evangelical (ORa = 1. 32; 95%CI 1. 14-1. 53), and with comorbidities (ORa = 1. 25; 95%CI 1. 07-1. 47). Having up to two doses of Covid-19 vaccine (ORa = 1. 30; 95%CI 1. 06-1. 59) and being unvaccinated while living with someone with comorbidities (ORa = 10. 34; 95%CI 2. 27-53. 48) also increased the odds of use. GVIF values were low except for city (8. 79), due to its interaction with income; the variable was retained for conceptual reasons. Sensitivity analyses yielded results consistent with the main model. CONCLUSION: The use of ineffective medications for Covid-19 prevention was higher among specific demographic groups, reflecting inequalities in access to information and the influence of religious factors. Scientific communication and community engagement strategies remain essential to combat misinformation.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Castanheira et al. (2026) studied this question.

synapsesocial.com/papers/69fecfafb9154b0b82876b6bhttps://doi.org/10.11606/s1518-8787.2026060006988
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Social inequalities in the misbelief of chloroquine’s protective effect against COVID-19: results from the EPICOVID-19 study in Brazil2026
  2. 2Adoção de comportamentos preventivos à Covid-19 na comunidade: Salvador e Rio de Janeiro2026
  3. 3Aceitabilidade do autoteste para Covid-19 entre usuários da Atenção Primária à Saúde2026
  4. 4Factors associated with COVID-19 vaccination schedule completion among adults in high-social-vulnerability neighborhoods in two Brazilian state capitals: A cross-sectional study2026
  5. 5Factors associated with adherence or hesitation to protective measures that influenced the control of COVID-19 in Brazil in the pre-vaccine era2024